NCT02486016View on ClinicalTrials.gov

Transdermal Patch CVD 2000: The Effect of Heat on Fentanyl Release From Fentanyl TDSs in Healthy Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 9, 2015

Primary Completion Date

August 8, 2017

Study Completion Date

August 9, 2017

Conditions
Peer Review, Research
Interventions
DRUG

Duragesic reference fentanyl TDS

25 µg/hour

DRUG

Apotex generic fentanyl TDS

25 µg/hour

DRUG

Mylan generic fentanyl TDS

25 µg/hour

Trial Locations (1)

21201

University of Maryland, Baltimore Center for Vaccine Development, Baltimore

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

University of Maryland, Baltimore

OTHER

NCT02486016 - Transdermal Patch CVD 2000: The Effect of Heat on Fentanyl Release From Fentanyl TDSs in Healthy Adults | Biotech Hunter | Biotech Hunter